Weight loss injections, particularly glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)which is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonisthave gained widespread attention for their effectiveness in treating obesity and type 2 diabetes
Nat Rev Nephrol 19 , 123138 (2023)
Do not stop Ozempic without consulting your healthcare provider
2H), which have in common the partial formation of EGT
So, once you pick your spot, it's time to inject
Ro does, via Foundayo (orforglipron), a once-daily FDA-approved pill with no food restrictions, starting at $149/month